BioCentury | Aug 17, 2020
Deals

Via $3.4B Principia takeout, Sanofi can explore potential of Btk inhibitor beyond MS

...first tranche of a $36 million series A round via New Leaf Venture Partners, OrbiMed, Morgenthaler Ventures...
BioCentury | Nov 15, 2019
Company News

Roche adds to fibrosis portfolio with $390M Promedior acquisition

...million across five venture financings from a syndicate that included Easton Capital Investment, HealthCare Ventures, Morgenthaler Ventures...
BioCentury | Aug 31, 2018
Financial News

Principia seeks IPO ahead of Phase III trials for Btk program

...NYSE:SNY) and AbbVie Inc. (NYSE:ABBV) that together could yield up to $1.4 billion in milestones. Morgenthaler Ventures...
BioCentury | Aug 20, 2018
Financial News

With Btk program bound for Phase III, Principia seeks IPO

...NYSE:SNY) and AbbVie Inc. (NYSE:ABBV) that together could yield up to $1.4 billion in milestones. Morgenthaler Ventures...
BioCentury | Jun 22, 2016
Financial News

Morgenthaler passes away

...Morgenthaler Ventures founder David Morgenthaler passed away on Monday at age 96. Morgenthaler also helped found...
BioCentury | Apr 25, 2016
Finance

Targeting pharma

...Venture Capital and Mayo Clinic . Existing investors also participated, including Advanced Technology Ventures , Morgenthaler Ventures...
BioCentury | Apr 25, 2016
Financial News

Second Genome completes venture financing

...Fund; Digitalis Ventures; Adveq; LifeForce Capital; MBL Venture Capital; Mayo Clinic ; Advanced Technology Ventures; Morgenthaler Ventures...
BioCentury | Apr 21, 2016
Financial News

Microbiome plays Second Genome, Enterome raise funds

...MBL Venture Capital and Mayo Clinic also participated, as did existing investors Advanced Technology Ventures, Morgenthaler Ventures...
BioCentury | Feb 29, 2016
Finance

Singapore swing

...the general partners and other members of life sciences teams of venture firms ATV and Morgenthaler Ventures...
BioCentury | Oct 5, 2015
Financial News

Elcelyx Therapeutics completes venture financing

...Date completed: 2015-10-01 Type: Venture financing Raised: $20 million Investors: Sailing Capital; Clough Capital Partners; Morgenthaler Ventures...
Items per page:
1 - 10 of 133
BioCentury | Aug 17, 2020
Deals

Via $3.4B Principia takeout, Sanofi can explore potential of Btk inhibitor beyond MS

...first tranche of a $36 million series A round via New Leaf Venture Partners, OrbiMed, Morgenthaler Ventures...
BioCentury | Nov 15, 2019
Company News

Roche adds to fibrosis portfolio with $390M Promedior acquisition

...million across five venture financings from a syndicate that included Easton Capital Investment, HealthCare Ventures, Morgenthaler Ventures...
BioCentury | Aug 31, 2018
Financial News

Principia seeks IPO ahead of Phase III trials for Btk program

...NYSE:SNY) and AbbVie Inc. (NYSE:ABBV) that together could yield up to $1.4 billion in milestones. Morgenthaler Ventures...
BioCentury | Aug 20, 2018
Financial News

With Btk program bound for Phase III, Principia seeks IPO

...NYSE:SNY) and AbbVie Inc. (NYSE:ABBV) that together could yield up to $1.4 billion in milestones. Morgenthaler Ventures...
BioCentury | Jun 22, 2016
Financial News

Morgenthaler passes away

...Morgenthaler Ventures founder David Morgenthaler passed away on Monday at age 96. Morgenthaler also helped found...
BioCentury | Apr 25, 2016
Finance

Targeting pharma

...Venture Capital and Mayo Clinic . Existing investors also participated, including Advanced Technology Ventures , Morgenthaler Ventures...
BioCentury | Apr 25, 2016
Financial News

Second Genome completes venture financing

...Fund; Digitalis Ventures; Adveq; LifeForce Capital; MBL Venture Capital; Mayo Clinic ; Advanced Technology Ventures; Morgenthaler Ventures...
BioCentury | Apr 21, 2016
Financial News

Microbiome plays Second Genome, Enterome raise funds

...MBL Venture Capital and Mayo Clinic also participated, as did existing investors Advanced Technology Ventures, Morgenthaler Ventures...
BioCentury | Feb 29, 2016
Finance

Singapore swing

...the general partners and other members of life sciences teams of venture firms ATV and Morgenthaler Ventures...
BioCentury | Oct 5, 2015
Financial News

Elcelyx Therapeutics completes venture financing

...Date completed: 2015-10-01 Type: Venture financing Raised: $20 million Investors: Sailing Capital; Clough Capital Partners; Morgenthaler Ventures...
Items per page:
1 - 10 of 133